Press Releases Bioventus Inc.

Equities

BVS

US09075A1088

Market Closed - Nasdaq Other stock markets 21:00:01 09/05/2024 BST			5-day change	1st Jan Change
5.461 ^USD	+8.36%		+37.91%	+3.63%

05-07	Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024	CI
05-07	Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bioventus : Q1'24 Earnings Call Slides	05-07	PU
Bioventus Reports First Quarter Financial Results	05-07	AQ
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024	04-29	AQ
Bioventus : Q4’23 Earnings Call Slides	03-12	PU
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	03-12	AQ
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	03-04	AQ
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	01-18	AQ
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole	01-12	AQ
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	12-27	BU
Bioventus Names Robert Claypoole as President and Chief Executive Officer	12-19	AQ
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis	12-06	AQ
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance	11-07	AQ
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023	31/10/23	AQ
Bioventus to Present at the Cantor Global Healthcare Conference	20/09/23	AQ
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference	06/09/23	AQ
Bioventus : Q2’23 Earnings Call Slides	08/08/23	PU
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance	08/08/23	AQ
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference	04/08/23	AQ
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023	01/08/23	AQ
BIOVENTUS INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	09/06/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Bioventus Inc.

Equities

BVS

US09075A1088

Press Releases

Filters